Physician profile
Robert Johnson
NPI 1356418479
$5,254.75
in general payments reported to CMS, 2019-2025
15 companies · $1,301 in 2025
The $1,301 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $496 · 2022: $1,521 · 2023: $895 · 2024: $1,041 · 2025: $1,301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,186 · Travel and Lodging: $51.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,185.72 |
| Travel and Lodging | $51.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $3,033.86 | 2021-2025 | Matrixrib, Matrixneuro, Xcm Biologic Tissue Matrix |
| Smith+Nephew, INC. | $430.66 | 2021-2022 | |
| Polynovo North America LLC | $375.27 | 2021-2025 | Novosorb Btm |
| Acera Surgical, INC. | $275.20 | 2025 | Restrata Wound Matrix |
| Intuitive Surgical, INC. | $256.26 | 2025 | |
| Avita Medical Americas, LLC | $217.91 | 2021-2024 | |
| Davol INC. | $193.60 | 2021-2024 | |
| Ethicon US, LLC | $149.42 | 2022-2025 | Monocryl, Echelon Flex, Contour |
| Boston Scientific Corporation | $111.27 | 2024 | |
| Astellas Pharma US INC | $85.05 | 2022 | |
| Vericel Corporation | $41.97 | 2022-2025 | Nexobrid |
| Kls-Martin L.P. | $25.59 | 2021-2022 | |
| Integra Lifesciences Corporation | $25.14 | 2022 | |
| Solventum Corporation | $19.62 | 2025 | V.A.C. Veraflo Cleanse Choice |
| Kci USA, INC. | $13.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.